Management & Regulatory

Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?
Management & Regulatory Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?

The fourth quarter of 2024 witnessed a significant surge in hedge fund investments focused on the healthcare sector, particularly emphasizing advancements in artificial intelligence (AI), biotechnology, and medical technology (MedTech). This pivotal period showcased growing confidence among

Is Columvi the Game-Changer for Refractory DLBCL Treatment?
Management & Regulatory Is Columvi the Game-Changer for Refractory DLBCL Treatment?

Roche's Columvi, a bispecific antibody known as glofitamab, has been approved by the European Commission (EC) for use in combination with gemcitabine and oxaliplatin (GemOx) to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in adults who are not candidates for autologous

Will Tariffs on Drugs Raise Costs and Worsen Shortages?
Management & Regulatory Will Tariffs on Drugs Raise Costs and Worsen Shortages?

The imposition of tariffs on pharmaceuticals presents a looming threat to medication costs and availability, especially considering Georgia's significant dependence on these imports. Initially exempt from recent global White House tariffs, this reprieve is under reconsideration, potentially

What Will Drive the Future of Nitinol Medical Devices?
Management & Regulatory What Will Drive the Future of Nitinol Medical Devices?

The realm of medical devices is on a transformative path, markedly influenced by the integration of advanced materials like Nitinol. Known for its remarkable superelasticity, shape memory effect, and superior damping characteristics, Nitinol stands as a cornerstone in the development of innovative

What Drives Growth in Global Medical Device Clinical Trials?
Management & Regulatory What Drives Growth in Global Medical Device Clinical Trials?

The global medical device clinical trials market is experiencing remarkable growth, with forecasts predicting an upward trajectory from USD 16.70 billion in 2024 to USD 30.53 billion by 2034. This substantial increase is largely driven by the pervasive rise in chronic diseases, which sets the stage

Navigating Medtech Challenges: Regulatory, Reshoring, and Tech Gaps
Management & Regulatory Navigating Medtech Challenges: Regulatory, Reshoring, and Tech Gaps

The medical and life sciences manufacturing sector is experiencing rapid transformations, bringing forth a plethora of challenges and opportunities for industry professionals. Ascential's "2025 State of Medical & Life Sciences Manufacturing" report delves into key areas such as

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later